US Patent 7598227 Modulation of apolipoprotein C-III expression
Patent 7598227 was granted and assigned to Ionis Pharmaceuticals on October, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 22 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 27 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Article (+409 characters)
Article
Patent abstract
Compounds, compositions and methods are provided for modulating the expression of apolipoprotein C-III. The compositions comprise oligonucleotides, targeted to nucleic acid encoding apolipoprotein C-III. Methods of using these compounds for modulation of apolipoprotein C-III expression and for diagnosis and treatment of disease associated with expression of apolipoprotein C-III are provided.
Edits on 2 Aug, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07598227 Modulation of apolipoprotein C-III expression US Patent 7598227 Modulation of apolipoprotein C-III expression
Infobox
Patent Number
0759822700
Patent Number
759822700
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 4 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075982270
Date of Patent
October 6, 2009
0Patent Application Number
104187800
Date Filed
April 16, 2003
0Official Website
Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075982270
Date of Patent
October 6, 2009
0Patent Application Number
104187800
Date Filed
April 16, 2003
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07598227 Modulation of apolipoprotein C-III expression
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07598227
Date of patent
October 6, 2009
Patent application number
10418780
Date Filed
April 16, 2003
Patent primary examiner
Find more entities like US Patent 7598227 Modulation of apolipoprotein C-III expression
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
